Encompass Health Corp. Form 8-K Summary
Business Context and Reporting Period
Encompass Health Corporation (EHC) filed this Current Report on Form 8-K on March 9, 2026. The filing details the entry into a new material definitive agreement to refinance its existing credit facilities and the termination of its prior credit agreement.
Key Financial Metrics and Debt Structure
- New Facility: Entered into a $1 billion revolving credit facility (2026 Credit Agreement) with Truist Bank as administrative agent.
- Subfacilities: Includes a $260 million letter of credit subfacility and a $40 million swingline subfacility.
- Drawdowns: As of March 9, 2026, the Company drew $250.0 million to repay the prior facility and $53.6 million on the letter of credit subfacility.
- Maturity: The new agreement matures on March 9, 2031.
- Covenants: Minimum Interest Coverage Ratio of 3.00:1.00; Maximum Leverage Ratio of 4.50:1.00 (net of cash), except for Significant Acquisitions.
- Accordion Feature: Allows for additional term loans or increased revolving commitments up to the greater of $1.4 billion or 100% of Adjusted Consolidated EBITDA, subject to a Senior Secured Leverage Ratio cap of 3.50:1.00.
Material Changes Versus Prior Period
The 2026 Credit Agreement replaced the Sixth Amended and Restated Credit Agreement dated October 7, 2022. Key changes include:
- Extended Maturity: Extended from October 7, 2027, to March 9, 2031.
- Reduced Fees: The fee for the undrawn portion of the revolving loan commitment was reduced by 5 basis points.
- Relaxed Covenants: Certain limitations on investments, debt incurrence, liens, and restricted payments have been relaxed.
- Interest Adjustment: The 0.10% adjustment to interest payable on Term SOFR Borrowings was eliminated.
- Increased Swingline: The swingline loan sublimit increased from $25 million to $40 million.
Outlook, Risks, and Contingencies
The filing does not provide specific forward-looking guidance on revenue or earnings. The primary risk disclosed relates to the Company's ability to maintain the required financial covenants (Interest Coverage and Leverage Ratios). The agreement is secured by current and future personal property of the Company and its subsidiary guarantors. The filing notes that lenders may engage in investment banking and commercial banking transactions with the Company in the ordinary course of business.
Investor Verification Checklist
- Verify the exact terms of the relaxed covenants regarding investments and restricted payments in the full Credit Agreement (Exhibit 10.1).
- Confirm the current Adjusted Consolidated EBITDA to assess the capacity available under the accordion feature.
- Review the Company's latest quarterly report to ensure compliance with the new 3.00:1.00 Interest Coverage Ratio and 4.50:1.00 Leverage Ratio covenants.
- Monitor the utilization of the $1 billion revolving facility, noting the initial draw of $250 million and $53.6 million in letters of credit.